MedTrace Logo

The Impact of GlowCaps Connect™ and Its Services on Hypertension Medication Adherence

NCT00985452 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2012-10-10

No results posted yet for this study

Summary

The investigators hypothesize that providing subjects on a once-a-day hypertension medication with GlowCaps ConnectTM will lead to an improvement in their medication adherence. The investigators propose to conduct a 6-month randomized control trial to assess the effect of the GlowCaps Connect™ system on the enhancement of hypertension medication adherence among subjects with a diagnosis of hypertension recruited from the greater Boston area. 130 subjects will be enrolled. Subjects will be randomized into either the control group or into one of two intervention groups.

Conditions

  • Medication Adherence

Interventions

OTHER

GlowCaps Connect system

The GlowCaps Connect system is an electronic medication reminder system, which provides reminders to help people to remember to take their medication.

OTHER

Glow cap system - deactivated

The Glow cap system - deactivated is an electronic medication system, which will track medication adherence.

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Joseph C Kvedar, MD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-08-31
Completion
2010-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00985452 on ClinicalTrials.gov